Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A1 | P18405 | 5/20 | 0.55 |
| ▸ | SRD5A2 | P31213 | 5/20 | 0.55 |
| ▸ | CNR2 | P34972 | 14/20 | 0.42 |
| ▸ | CNR1 | P21554 | 6/20 | 0.42 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8959679 | 1.00 | SRD5A1 (0.55) | SRD5A1SRD5A2CNR2CNR1CREBBP | |
| SCHEMBL8959858 | 0.85 | SRD5A1 (0.58) | SRD5A1SRD5A2CNR2CNR1CREBBP | |
| SCHEMBL8959973 | 0.84 | SRD5A1 (0.59) | SRD5A1SRD5A2CNR2CNR1 | |
| SCHEMBL9334036 | 0.80 | SRD5A1 (0.79) | SRD5A1SRD5A2CNR2CNR1 | |
| SCHEMBL8432773 | 0.80 | SRD5A1 (0.79) | SRD5A1SRD5A2CNR2CNR1 | |
| SCHEMBL9334029 | 0.80 | SRD5A1 (0.79) | SRD5A1SRD5A2CNR2CNR1 | |
| SCHEMBL8959983 | 0.79 | SRD5A1 (0.53) | SRD5A1SRD5A2 | |
| SCHEMBL8959617 | 0.79 | SRD5A1 (0.59) | SRD5A1SRD5A2CNR2CNR1CREBBP | |
| SCHEMBL8959613 | 0.79 | SRD5A1 (0.59) | SRD5A1SRD5A2CNR2CNR1CREBBP | |
| SCHEMBL9334061 | 0.78 | SRD5A1 (0.78) | SRD5A1SRD5A2CNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5530019-A | FOR TREATMENT OF PROSTATE GLAND DISORDERS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-06-25 | — | — | US | disclosed |